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Background. Postmenopausal is characterized with reduced bone formation, 
increased bone resorption, consecutive bone loss and osteoporosis development.
Methods. Basal serum levels of bone formation marker osteocalcin (OC) and bone 
resorption marker CTX and their levels after 3, 6 and 12 months of 70mg 
alendronate treatment (AT) were determined with electrochemiluminescence
method, automatic imunoanalyser Roche Elecsys 2010. Postmenopausal women 
(n=100) with osteoporosis, diagnosed with DEXA bone density measurement, with 
mean age (59.35±5yr.), menopause duration (11.65±6.3yr.) were studied.
Results. CTX values after 3 months AT (0.2±0.12ng/ml) are lower compared to 
the basal levels (0.48±0.12ng/ml)(p<0.0001), but higher compared to 6 months 
(0.12±0.06ng/ml)(p<0.003), and 12 months AT (0.09±0.07ng/ml)(p<0.0001). CTX 
levels after 6 month AT are lower compared to basal levels (p<0.0001), and 3 
months AT (p<0.003), but were not significantly different compared to 12 
months AT (p>0.05). OC levels after 3 months AT (18.71±5.95ng/ml) are lower 
compared to basal levels (26.52±8.63ng/ml)(p<0.001), but not significantly higher 
compared to 6 months (15.49±5.18ng/ml)(p<0.019), and 12 months AT 
(13.23±3.86ng/ml)(p<0.0001). OC levels after 6 months are lower than basal 
levels (p<0.0001), and compared to 3 months AT (p<0.019), but are not 
significantly different compared to 12 months AT (p>0.05).
Conclusions. AT enabled progressive and significant reduction of CTX and OC 
level after 3, 6 and 12 months, but after 6 to 12 months the reduction is not 
significant. Optimal antiresorptive effect is achieved after 6 months of AT and 
it is persistent after 12 months of AT.
